ALOX12 and cancer: Given that ALOX12 usually functions in many types of cancer cells [12], the discovery of TPCI as a photo-induced ALOX12 activator renders a viable therapeutic approach on the basis of distinct ferroptosis of cancer cells, without limiting to their intrinsic ACSL4 expression levels.